Enjoy complimentary customisation on priority with our Enterprise License!
A few of the key findings from our psoriatic arthritis therapeutics market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.
Difficulty in identifying the pathogenesis of psoriatic arthritis has resulted in the lack of curative therapies for the indication. This has driven market vendors and research organizations to focus on the development of regenerative therapies such as stem cell therapy for curing psoriatic arthritis. One such development is the administration of umbilical cord Wharton’s Jelly stem cells (WJSCs) in psoriatic arthritis patients. Studies conducted by Invitrx Inc. have also shown that the human umbilical cord stem cell therapy can provide complete remission of symptoms such as joint pain and psoriatic plaques and normalize inflammatory markers C-reactive protein and erythrocyte sedimentation rate. These methods of treatment have proven to be highly effective in curing psoriatic arthritis. Although these regenerative therapies are in the early stages of development, further advances in research will boost their demand for the identification of pathogenesis and cause of psoriatic arthritis. Thus, the advent of regenerative therapy has been identified as one of the critical psoriatic arthritis therapeutics market trends. The trend will have a positive influence on the growth of the market over the forecast period.
The expiry of patents of most of the drugs in the global PsA therapeutics market has resulted in the development of biosimilars of significant therapeutics. Although biosimilars are reasonably priced, their cost is still higher than small molecule drugs. The high efficacy of biologics in the treatment of psoriatic arthritis therapeutics is also responsible for their increased sales. These factors are restricting the growth of small molecule drugs. Moreover, the patent expansion of the key blockbuster drug, HUMIRA, will help in partially offsetting the value erosion caused by the entry of biosimilars. As a result, the dominance of biologics will grow and drive the psoriatic arthritis therapeutics market growth at a CAGR of almost 9% during the forecast period.
The global psoriatic arthritis therapeutics market is concentrated. To help clients in improving their market positions, the report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, the market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.
The report offers a detailed analysis of several leading psoriatic arthritis therapeutics companies, including:
The biologics segment will account for the highest psoriatic arthritis therapeutics market share. The strong efficacy of approved drugs, availability of patient assistance programs, strong patient pool, and increasing awareness campaigns are a few of the factors fueling the growth of the segment. The report provides an accurate prediction of the contribution of all the segments to the growth of the psoriatic arthritis therapeutics market size.
With a complete study of the growth opportunities for the companies, it has been identified that North America will account for the highest share of the PsA therapeutics market throughout the forecast period. Factors such as strong dominance of biologics, availability of various patient assistance programs, and the presence of advanced healthcare infrastructure are contributing to the growth of the market in the region.
We can help! Our analysts can customize the market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
PART 16: EXPLORE TECHNAVIO
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.